XML 30 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments and Geographic Information
 9 Months Ended
Jun. 25, 2016
Segment Reporting [Abstract]  
Business Segments and Geographic Information
Business Segments and Geographic Information
The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring, divestiture and facility consolidation charges and other one-time or unusual items.
Identifiable assets for the four principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues during the three and nine months ended June 25, 2016 and June 27, 2015. Segment information is as follows:
 
Three Months Ended
 
Nine Months Ended
 
June 25,
2016
 
June 27,
2015
 
June 25,
2016
 
June 27,
2015
Total revenues:
 
 
 
 
 
 
 
Diagnostics
$
309.9

 
$
306.9

 
$
925.0

 
$
907.7

Breast Health
282.5

 
279.5

 
820.5

 
777.1

GYN Surgical
102.0

 
85.5

 
291.6

 
248.9

Skeletal Health
23.0

 
22.0

 
68.7

 
68.5

 
$
717.4


$
693.9


$
2,105.8


$
2,002.2

Income from operations:
 
 
 
 
 
 
 
Diagnostics
$
31.7

 
$
30.0

 
$
97.6

 
$
85.3

Breast Health
90.8

 
74.7

 
250.7

 
210.7

GYN Surgical
16.8

 
9.5

 
49.2

 
27.2

Skeletal Health
0.1

 
1.8

 
4.1

 
6.2

 
$
139.4


$
116.0

 
$
401.6

 
$
329.4

Depreciation and amortization:
 
 
 
 
 
 
 
Diagnostics
$
90.6

 
$
88.8

 
$
258.0

 
$
269.2

Breast Health
5.1

 
5.9

 
17.5

 
21.8

GYN Surgical
24.9

 
25.6

 
74.4

 
77.0

Skeletal Health
0.3

 
0.3

 
0.9

 
1.1

 
$
120.9


$
120.6


$
350.8


$
369.1

Capital expenditures:
 
 
 
 
 
 
 
Diagnostics
$
12.7

 
$
12.4

 
$
37.6

 
$
38.6

Breast Health
2.4

 
2.8

 
7.7

 
8.4

GYN Surgical
4.1

 
2.2

 
10.9

 
6.6

Skeletal Health
0.1

 
0.1

 
0.4

 
0.3

Corporate
1.8

 
0.9

 
6.2

 
4.2

 
$
21.1


$
18.4


$
62.8


$
58.1

 
 
June 25,
2016
 
September 26,
2015
Identifiable assets:
 
 
 
Diagnostics
$
3,824.9

 
$
4,055.8

Breast Health
808.5

 
815.4

GYN Surgical
1,591.5

 
1,658.1

Skeletal Health
32.9

 
25.3

Corporate
1,048.9

 
1,115.5

 
$
7,306.7

 
$
7,670.1


The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June 25, 2016 and June 27, 2015.
The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
June 25,
2016
 
June 27,
2015
 
June 25,
2016
 
June 27,
2015
United States
78.7
%
 
77.8
%
 
78.7
%
 
75.8
%
Europe
10.6
%
 
11.3
%
 
10.3
%
 
12.2
%
Asia-Pacific
7.5
%
 
7.9
%
 
7.6
%
 
8.5
%
All others
3.2
%
 
3.0
%
 
3.4
%
 
3.5
%
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%